Cargando…

Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications

Detalles Bibliográficos
Autores principales: Gerds, Aaron T., Bose, Prithviraj, Hobbs, Gabriela S., Kuykendall, Andrew T., Neilson, Lynn M., Song, Jinlin, Klencke, Barbara, Harrison, Claire N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529047/
https://www.ncbi.nlm.nih.gov/pubmed/36204692
http://dx.doi.org/10.1097/HS9.0000000000000778
_version_ 1784801420608798720
author Gerds, Aaron T.
Bose, Prithviraj
Hobbs, Gabriela S.
Kuykendall, Andrew T.
Neilson, Lynn M.
Song, Jinlin
Klencke, Barbara
Harrison, Claire N.
author_facet Gerds, Aaron T.
Bose, Prithviraj
Hobbs, Gabriela S.
Kuykendall, Andrew T.
Neilson, Lynn M.
Song, Jinlin
Klencke, Barbara
Harrison, Claire N.
author_sort Gerds, Aaron T.
collection PubMed
description
format Online
Article
Text
id pubmed-9529047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95290472022-10-05 Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications Gerds, Aaron T. Bose, Prithviraj Hobbs, Gabriela S. Kuykendall, Andrew T. Neilson, Lynn M. Song, Jinlin Klencke, Barbara Harrison, Claire N. Hemasphere Perspective Lippincott Williams & Wilkins 2022-09-30 /pmc/articles/PMC9529047/ /pubmed/36204692 http://dx.doi.org/10.1097/HS9.0000000000000778 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Perspective
Gerds, Aaron T.
Bose, Prithviraj
Hobbs, Gabriela S.
Kuykendall, Andrew T.
Neilson, Lynn M.
Song, Jinlin
Klencke, Barbara
Harrison, Claire N.
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title_full Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title_fullStr Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title_full_unstemmed Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title_short Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
title_sort treating anemic patients with myelofibrosis in the new janus kinase inhibitor era: current evidence and real-world implications
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529047/
https://www.ncbi.nlm.nih.gov/pubmed/36204692
http://dx.doi.org/10.1097/HS9.0000000000000778
work_keys_str_mv AT gerdsaaront treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT boseprithviraj treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT hobbsgabrielas treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT kuykendallandrewt treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT neilsonlynnm treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT songjinlin treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT klenckebarbara treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications
AT harrisonclairen treatinganemicpatientswithmyelofibrosisinthenewjanuskinaseinhibitoreracurrentevidenceandrealworldimplications